
The randomized controlled trial assessed the analgesic efficacy of combining dexamethasone, magnesium sulfate, and dexmedetomidine with ropivacaine for supraclavicular brachial plexus block in arthroscopic shoulder surgery. Eighty patients were divided into four groups (DMD, DM, M, and D). Group DMD (dexamethasone 10 mg, dexmedetomidine 50 µg, magnesium sulfate 250 mg, and ropivacaine 100 mg) exhibited significantly longer time to first request for analgesia and reduced cumulative opioid consumption at 18 and 24 hours compared to other groups. Visual Analogue Scale (VAS) scores were significantly lower in Group DMD at 6 and 12 hours postoperatively. The combination of dexamethasone, dexmedetomidine, and magnesium sulfate with ropivacaine offers superior analgesia compared to other adjuncts.
Like
Save
Share